Breaking: Pfizer reports Q2 2021 earnings ,beats on EPS and Revenue, raises guidance

Pfizer (PFE) reported Q2 2021 earnings on Wednesday, July 28 before the market opened. Pfizer reported Earnings Per Share (EPS) of $1.07 versus the average Wall Street analyst estimate of $0.96.

Revenue was $19 billion versus the average analyst estimate of $18.45 billion.

Pfizer also raised its full-year guidance from $70.5-72.5 billion to $78-80 billion and raises full-year EPS guidance from $3.55-3.65 to $3.95-4.05 range. 

Pfizer raised sales forecasts for sales of the Covid-19 vaccine to $33.5 billion from $26 billion.

Pfizer stock forecast

Pfizer (PFE) stock is trading at $42.40 in Wednesday's premarket, a change of 0.7% . Pfizer closed Tuesday's regular session at $42.10, a change of +0.69% on Tuesday.